. 2021 Jan 8;2021:1632957. doi: 10.1155/2021/1632957

Table 4.

Comparison of changes in the antioxidant markers during the study period between the placebo and EENO groups.

Variable		Baseline	After 4 weeks	P value	Net differences of groups	P value
TAC (mM)	Control	0.72 ± 0.25	0.63 ± 0.3	P < 0.09	−0.09 ± 0.24	P < 0.39
TAC (mM)	Intervention	0.7 ± 0.25	0.7 ± 0.3	P < 0.77	0.009 ± 0.29	P < 0.39
TOS (µM)	Control	9.5 ± 2.3	5.9 ± 2.3	P < 0.001^∗∗∗	−3.6 ± 3.3	P < 0.47
TOS (µM)	Intervention	11.3 ± 3.3	6.9 ± 2.4	P < 0.001^∗∗∗	−4.4 ± 4.2	P < 0.47
GPX (U/mL)	Control	223 ± 115	252.9 ± 107.8	P < 0.17	29.9 ± 7.8	P < 0.54
GPX (U/mL)	Intervention	164.2 ± 103.6	173.3 ± 134.4	P < 0.56	9.1 ± 134.8	P < 0.54
T-SH (mmol/L)	Control	10.1 ± 4.1	5.6 ± 3.2	P < 0.001^∗∗∗	−4.5 ± 5.5	P < 0.323
T-SH (mmol/L)	Intervention	13.1 ± 5.3	7.4 ± 4.3	P < 0.001^∗∗∗	−5.6 ± 5.5	P < 0.323
MDA (mmol/L)	Control	1.5 ± 0.14	0.67 ± 0.22	P < 0.001^∗∗∗	−0.86 ± 0.26	P < 0.001^∗∗
MDA (mmol/L)	Intervention	1.6 ± 0.13	0.42 ± 0.27	P < 0.001^∗∗∗	−1.1 ± 0.28	P < 0.001^∗∗
SOD (U/mL)	Control	28.3 ± 8.1	33.8 ± 5.7	P < 0.001^∗∗∗	5.5 ± 4.9	P < 0.32
SOD (U/mL)	Intervention	29.3 ± 6.3	37.1 ± 8.4	P < 0.001^∗∗∗	7.8 ± 10	P < 0.32

TAC, total antioxidant capacity; TOS, total oxidant status; GPX, glutathione peroxidase; T-SH, sulfhydryl protein; MDA, malondialdehyde; SOD, superoxide dismutase ^∗∗(P < 0.01) and ^∗∗∗(P < 0.001).